4.6 Article

SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells

Related references

Note: Only part of the references are listed.
Article Virology

Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein

Suresh Kumar et al.

Summary: The emergence of the new SARS-CoV-2 variant, Omicron, has raised concerns due to its potential high affinity for human ACE2, indicating a higher transmission potential. Compared to the Delta variant, Omicron has a significantly different amino acid composition and protein structure, which may affect its stability and ACE2 binding.

JOURNAL OF MEDICAL VIROLOGY (2022)

Article Multidisciplinary Sciences

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

Sandile Cele et al.

Summary: The study found that the Omicron variant has reduced neutralizing effectiveness in individuals vaccinated with Pfizer BNT162b2, but those who had previously been infected with SARS-CoV-2 showed better neutralization against Omicron.

NATURE (2022)

Article Genetics & Heredity

Genome-scale CRISPR screens identify host factors that promote human coronavirus infection

Marco Grodzki et al.

Summary: This study identified multiple host genes and pathways that promote SARS-CoV-2 infection through genome-scale CRISPR knockout screens. It also revealed the importance of host factors involved in cell cycle regulation and programmed mRNA decay pathway in coronavirus replication. Additionally, novel antiviral compounds targeting these factors were identified.

GENOME MEDICINE (2022)

Article Immunology

SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells

Hanjun Zhao et al.

Summary: The Omicron variant of SARS-CoV-2 has distinct virological characteristics compared to the Delta variant. It replicates more slowly and its entry pathway is mediated primarily through the endocytic pathway instead of TMPRSS2 pathway. This difference in entry pathway may have implications for the clinical manifestations or severity of the disease.

EMERGING MICROBES & INFECTIONS (2022)

Article Virology

Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?

Christoph Jung et al.

Summary: The recently identified Omicron variant of SARS-CoV-2 is the fifth variant of concern and is characterized by significant changes in the viral Spike protein, possibly leading to increased transmission efficiency and evasion of neutralizing antibodies. Despite quickly outcompeting the Delta variant, Omicron appears to be overall less pathogenic than other variants.

JOURNAL OF VIROLOGY (2022)

Article Virology

IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection

Massimo Palatini et al.

Summary: This study identified IFITM3 as a novel protein-protein interaction partner of NTCP, which significantly affects the infection of HBV and HDV in hepatoma cells and primary human hepatocytes expressing NTCP. However, the specific mechanism by which this interaction facilitates the infection process remains unknown.

VIRUSES-BASEL (2022)

Review Biotechnology & Applied Microbiology

D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity

Manojit Bhattacharya et al.

Summary: The COVID-19 pandemic has resulted in the emergence of numerous global variants of SARS-CoV-2, with the D614G mutation playing a key role in enhancing infectivity and immune evasion capabilities in these variants.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2021)

Article Biochemistry & Molecular Biology

Opposing activities of IFITM proteins in SARS-CoV-2 infection

Guoli Shi et al.

Summary: The study reveals that some IFITMs can restrict SARS-CoV-2 infections while others enhance infections, with IFITM3 showing new antiviral mechanisms involving amphipathic helix and endocytosis-promoting motif. These findings provide insights into the dual roles of IFITM3 in enhancing viral infection at the plasma membrane and restricting endosomal SARS-CoV-2.

EMBO JOURNAL (2021)

Article Infectious Diseases

Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021

Vitor Borges et al.

Summary: The study found that the B.1.1.7 lineage of SARS-CoV-2 is highly disseminated in Portugal, with an estimated 89% increase per week. RT-PCR spike gene target late detection (SGTL) can be a useful tool to track the spread, showing higher viral loads in SGTL/SGTF samples without significant age distribution shifts.

EUROSURVEILLANCE (2021)

Article Multidisciplinary Sciences

Detection of a SARS-CoV-2 variant of concern in South Africa

Houriiyah Tegally et al.

Summary: The article describes a newly emerged lineage of SARS-CoV-2, 501Y.V2, characterized by eight mutations in the spike protein, which may result in increased transmissibility or immune escape. This lineage originated in South Africa and quickly became dominant in Eastern Cape, Western Cape, and KwaZuluNatal provinces within weeks.

NATURE (2021)

Article Multidisciplinary Sciences

COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets

Toni M. Delorey et al.

Summary: This study using single-cell and spatial atlases revealed the impact of COVID-19 infection on lung, kidney, liver, and heart tissues, showing structural remodeling and viral RNA enrichment. Differences in lung inflammatory responses and transcriptional alterations in heart tissue of COVID-19 patients were also identified, along with cell types and genes associated with disease severity.

NATURE (2021)

Article Multidisciplinary Sciences

Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil

Nuno R. Faria et al.

Summary: A new variant of concern, P.1, with 17 mutations including three spike protein mutations associated with increased binding to human ACE2 receptors, emerged in Manaus, Brazil between November 2020 and January 2021. Molecular analysis suggests P.1 may be 1.7- to 2.4-fold more transmissible and that previous infection may provide 54 to 79% protection against P.1 infection compared to other lineages. Enhanced global genomic surveillance of such variants is crucial for pandemic response.

SCIENCE (2021)

Article Biochemistry & Molecular Biology

The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages

Darren P. Martin et al.

Summary: The emergence of the 501Y lineages of SARS-CoV-2 in 2020 coincided with a global shift in selective forces acting on various genes, leading to repeated convergent mutations at 35 genome sites known as the 501Y meta-signature. This meta-signature includes multiple mutation combinations that promote the persistence of diverse SARS-CoV-2 lineages in the face of increasing host immune recognition.
Review Cell Biology

Advancing lung organoids for COVID-19 research

Jelte van der Vaart et al.

Summary: The COVID-19 pandemic highlighted the necessity of developing effective treatments against emerging viruses. Collaborations between cell biologists and virologists have rapidly advanced representative organoid model systems, particularly lung organoids, for studying SARS-CoV-2 and future pandemic viruses, paving the way for effective treatments.

DISEASE MODELS & MECHANISMS (2021)

Article Biochemistry & Molecular Biology

TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells

Jana Koch et al.

Summary: SARS-CoV-2 infects cells through two mutually exclusive pathways depending on the presence of TMPRSS2 protease. In the presence of TMPRSS2, the virus swiftly enters through the plasma membrane in a pH-independent manner; while in the absence of TMPRSS2, the virus is endocytosed and enters the cytosol post-infection.

EMBO JOURNAL (2021)

Review Microbiology

The rapid adaptation of SARS-CoV-2-rise of the variants: transmission and resistance

Sandrine M. Soh et al.

Summary: The causative factor of COVID-19, SARS-CoV-2, is continuously mutating, with identified mutations mainly occurring in the spike (S) protein interacting with the ACE2 receptor. Some mutated strains are becoming dominant globally due to increased transmissibility and cell entry efficacy, resulting in significantly reduced neutralizing activity against these variants by monoclonal antibodies, convalescent sera, and vaccines. This raises concerns about the efficacy of various monoclonal antibodies therapy and vaccines against the evolving variants.

JOURNAL OF MICROBIOLOGY (2021)

Review Microbiology

SARS-CoV-2 variants, spike mutations and immune escape

William T. Harvey et al.

Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.

NATURE REVIEWS MICROBIOLOGY (2021)

Article Multidisciplinary Sciences

IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro

Caterina Prelli Bozzo et al.

Summary: IFITM proteins can restrict viral pathogens, but they also support efficient infection of SARS-CoV-2 in human lung cells. The spike protein of SARS-CoV-2 interacts with IFITMs and hijacks them for viral infection, making IFITM proteins potential therapeutic targets for inhibiting virus entry and replication.

NATURE COMMUNICATIONS (2021)

Review Microbiology

Cellular host factors for SARS-CoV-2 infection

Jim Baggen et al.

Summary: This review summarizes proviral host factors required for SARS-CoV-2 infection, important cellular processes in SARS-CoV-2 replication, and host factors that could be targeted for antiviral therapies for COVID-19.

NATURE MICROBIOLOGY (2021)

Article Microbiology

SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India

Sarah Cherian et al.

Summary: Genomic epidemiology and whole genome sequencing were used to investigate the transmission and evolution of the SARS-CoV-2 virus during the global pandemic. The study identified new variants B.1.617.1 and B.1.617.2 in India, responsible for the second wave of COVID-19 in Maharashtra, with B.1.617.2 designated as a VOC delta and B.1.617.1 as a variant of interest kappa. Monitoring of these and emerging variants in India is crucial for public health.

MICROORGANISMS (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

Petra Mlcochova et al.

Summary: The B.1.617.2 (Delta) variant of SARS-CoV-2 has lower sensitivity to antibodies and higher replication efficiency compared to other lineages, which may contribute to its dominance and reduced vaccine effectiveness, highlighting the need for continued infection control measures post-vaccination.

NATURE (2021)

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Detection of SARS-CoV-2 in human breastmilk

Rüdiger Groß et al.

LANCET (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

Waradon Sungnak et al.

NATURE MEDICINE (2020)

Article Biochemistry & Molecular Biology

Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

Leonid Yurkovetskiy et al.

Article Biochemistry & Molecular Biology

Syncytia formation by SARS-CoV-2-infected cells

Julian Buchrieser et al.

EMBO JOURNAL (2020)

Article Biochemical Research Methods

Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells

Anjali Jacob et al.

NATURE PROTOCOLS (2019)

Review Microbiology

IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections

Xuesen Zhao et al.

FRONTIERS IN MICROBIOLOGY (2019)

Article Biotechnology & Applied Microbiology

An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar

Nathan D. Grubaugh et al.

GENOME BIOLOGY (2019)

Article Cell & Tissue Engineering

Differentiation of Human Pluripotent Stem Cells into Functional Lung Alveolar Epithelial Cells

Anjali Jacob et al.

CELL STEM CELL (2017)

Article Microbiology

IFITM Proteins Incorporated into HIV-1 Virions Impair Viral Fusion and Spread

Alex A. Compton et al.

CELL HOST & MICROBE (2014)

Article Multidisciplinary Sciences

Interferon induction of IFITM proteins promotes infection by human coronavirus OC43

Xuesen Zhao et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Virology

IFITM-Family Proteins: The Cell's First Line of Antiviral Defense

Charles C. Bailey et al.

ANNUAL REVIEW OF VIROLOGY, VOL 1 (2014)

Article Biochemistry & Molecular Biology

Interferon-induced Transmembrane Protein 3 Is a Type II Transmembrane Protein

Charles C. Bailey et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Article Microbiology

IFITM Proteins Restrict Viral Membrane Hemifusion

Kun Li et al.

PLOS PATHOGENS (2013)

Review Immunology

The broad-spectrum antiviral functions of IFIT and IFITM proteins

Michael S. Diamond et al.

NATURE REVIEWS IMMUNOLOGY (2013)

Article Biochemical Research Methods

The Sequence Alignment/Map format and SAMtools

Heng Li et al.

BIOINFORMATICS (2009)